Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.6.3751

Roles of microRNA-206 in Osteosarcoma Pathogenesis and Progression  

Bao, Yun-Ping (Medical School of Yangtze University, The First People's Hospital of Jingzhou)
Yi, Yang (Department of Orthopedics, The First People's Hospital of Jingzhou)
Peng, Li-Lin (Department of Orthopedics, The First People's Hospital of Jingzhou)
Fang, Jing (Department of Neurology, The Second People's Hospital of Jingzhou)
Liu, Ke-Bin (Department of Orthopedics, The First People's Hospital of Jingzhou)
Li, Wu-Zhou (Department of Orthopedics, The First People's Hospital of Jingzhou)
Luo, Hua-Song (Department of Orthopedics, The First People's Hospital of Jingzhou)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.6, 2013 , pp. 3751-3755 More about this Journal
Abstract
Backgroud and Aims: MicroRNA-206 has proven to be down-regulated in many human malignancies in correlation with tumour progression. Our study aimed to characterize miR-206 contributions to initiation and malignant progression of human osteosarcoma. Methods: MiR-206 expression was detected in human osteosarcoma cell 1ine MG63, human normal osteoblastic cell line hFOB 1.19, and paired osteosarcoma and normal adjacent tissues from 65 patients using quantitative RT-PCR. Relationships of miR-206 levels to clinicopathological characteristics were also investigated. Moreover, miR-206 mimics and negative control siRNA were transfected into MG63 cells to observe effects on cell viability, apoptosis, invasion and migration. Results: We found that miR-206 was down-regulated in the osteosarcoma cell line MG63 and primary tumor samples, and decreased miR-206 expression was significantly associated with advanced clinical stage, T classification, metastasis and poor histological differentiation. Additionally, transfection of miR-206 mimics could reduce MG-63 cell viability, promote cell apoptosis, and inhibit cell invasion and migration. Conclusions: These findings indicate that miR-206 may have a key role in osteosarcoma pathogenesis and development. It could serve as a useful biomarker for prediction of osteosarcoma progression, and provide a potential target for gene therapy.
Keywords
MicroRNA-206; osteosarcoma; tumor stage; metastasis; invasion; migration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alley MC, Scudiero DA, Monks A, et al (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res, 48, 589-601.
2 Ambros V (2003). MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell, 113, 673-6.   DOI   ScienceOn
3 Bartel DP, and Chen CZ (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet, 5, 396-400.
4 Calin GA, Dumitru CD, Shimizu M, et al (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99, 15524-9.   DOI   ScienceOn
5 Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101, 2999-3004.   DOI   ScienceOn
6 Casalini P, and Iorio MV (2009). MicroRNAs and future therapeutic applications in cancer. J Buon, 14, S17-22.
7 Chen X, Yan Q, Li S, et al (2012). Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett, 314, 41-53.   DOI   ScienceOn
8 Cho Y, Jung GH, Chung SH, et al (2011). Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution. Clin Orthop Surg, 3, 48-54.   DOI   ScienceOn
9 Fabian MR, and Sonenberg N (2012). The mechanics of miRNAmediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol, 19, 586-93.   DOI   ScienceOn
10 Geller DS, and Gorlick R (2010). Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol, 8, 705-18.
11 Iorio MV, Ferracin M, Liu CG, et al (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70.   DOI   ScienceOn
12 Jovanovic M, and Hengartner MO (2006). miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-87.   DOI   ScienceOn
13 Kobayashi E, Hornicek FJ, and Duan Z (2012). MicroRNA Involvement in Osteosarcoma. Sarcoma, 2012, 359739.
14 Kondo N, Toyama T, Sugiura H, et al (2008). miR-206 Expression is down-regulated in estrogen receptor alphapositive human breast cancer. Cancer Res, 68, 5004-8.   DOI   ScienceOn
15 Krek A, Grun D, Poy MN, et al (2005). Combinatorial microRNA target predictions. Nat Genet, 37, 495-500.   DOI   ScienceOn
16 Leivonen SK, Makela R, Ostling P, et al (2009). Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene, 28, 3926-36.   DOI   ScienceOn
17 Lewis VO (2009). What’s new in musculoskeletal oncology. J Bone Joint Surg Am, 91, 1546-56.   DOI   ScienceOn
18 Liu ZY, Zhang GL, Wang MM, et al (2011). MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. Asian Pac J Cancer Prev, 12, 2819-23.
19 Marina N, Gebhardt M, Teot L, and Gorlick R (2004). Biology and therapeutic advances for pediatric osteosarcoma. Oncologist, 9, 422-41.   DOI   ScienceOn
20 Missiaglia E, Shepherd CJ, Patel S, et al (2010). MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer, 102, 1769-77.   DOI   ScienceOn
21 Miyachi M, Tsuchiya K, Yoshida H, et al (2010). Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun, 400, 89-93.   DOI   ScienceOn
22 Schmittgen TD, and Livak KJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3, 1101-8.   DOI   ScienceOn
23 Song G, Zhang Y, and Wang L (2009). MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem, 284, 31921-7.   DOI   ScienceOn
24 Song T, Xia W, Shao N, et al (2010). Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev, 11, 905-11.
25 Taulli R, Bersani F, Foglizzo V, et al (2009). The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest, 119, 2366-78.
26 Vickers MM, Bar J, Gorn-Hondermann I, et al (2012). Stagedependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis, 29, 123-32.   DOI   ScienceOn
27 Wang X, Ling C, Bai Y, and Zhao J (2011). MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec, 294, 88-92.   DOI   ScienceOn
28 Zhang T, Liu M, Wang C, et al (2011). Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res, 31, 3859-63.